ID   XPO2_HUMAN              Reviewed;         971 AA.
AC   P55060; A3RLL6; B2R5T4; E1P5Y0; F8W904; O75432; Q32M40; Q9H5B7; Q9NTS0;
AC   Q9UP98; Q9UP99; Q9UPA0;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   29-MAR-2005, sequence version 3.
DT   28-JUN-2023, entry version 207.
DE   RecName: Full=Exportin-2;
DE            Short=Exp2;
DE   AltName: Full=Cellular apoptosis susceptibility protein {ECO:0000303|PubMed:7479798};
DE   AltName: Full=Chromosome segregation 1-like protein;
DE   AltName: Full=Importin-alpha re-exporter;
GN   Name=CSE1L; Synonyms=CAS {ECO:0000303|PubMed:7479798}, XPO2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Placenta;
RX   PubMed=7479798; DOI=10.1073/pnas.92.22.10427;
RA   Brinkmann U., Brinkmann E., Gallo M., Pastan I.;
RT   "Cloning and characterization of a cellular apoptosis susceptibility gene,
RT   the human homologue to the yeast chromosome segregation gene CSE1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:10427-10431(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1; 2 AND 3), AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=10331944; DOI=10.1006/geno.1998.5700;
RA   Brinkmann U., Brinkmann E., Bera T.K., Wellmann A., Pastan I.;
RT   "Tissue-specific alternative splicing of the CSE1L/CAS (cellular apoptosis
RT   susceptibility) gene.";
RL   Genomics 58:41-49(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RX   PubMed=11703094; DOI=10.1006/mcbr.2001.0303;
RA   Jiang M.C., Lin T.L., Lee T.L., Huang H.T., Lin C.L., Liao C.F.;
RT   "IRF-1-mediated CAS expression enhances interferon-gamma-induced apoptosis
RT   of HT-29 colon adenocarcinoma cells.";
RL   Mol. Cell Biol. Res. Commun. 4:353-358(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,
RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,
RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,
RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,
RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,
RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,
RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,
RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,
RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,
RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,
RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 1-16; 18-26; 32-67; 76-83; 94-109; 138-151; 166-217;
RP   252-268; 282-288; 293-309; 332-371; 373-382; 396-418; 428-440; 446-481;
RP   560-574; 698-736; 769-777; 789-816; 825-832 AND 913-934, ACETYLATION AT
RP   MET-1, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma;
RA   Bienvenut W.V.;
RL   Submitted (JUN-2005) to UniProtKB.
RN   [9]
RP   PROTEIN SEQUENCE OF 356-370, FUNCTION IN PROTEIN NUCLEAR EXPORT,
RP   IDENTIFICATION IN A COMPLEX WITH RAN AND KPNA2, AND SUBCELLULAR LOCATION.
RX   PubMed=9323134; DOI=10.1016/s0092-8674(00)80372-4;
RA   Kutay U., Bischoff F.R., Kostka S., Kraft R., Goerlich D.;
RT   "Export of importin-alpha from the nucleus is mediated by a specific
RT   nuclear transport factor.";
RL   Cell 90:1061-1071(1997).
RN   [10]
RP   INTERACTION WITH KPNA2.
RX   PubMed=9786944; DOI=10.1083/jcb.143.2.309;
RA   Herold A., Truant R., Wiegand H., Cullen B.R.;
RT   "Determination of the functional domain organization of the importin alpha
RT   nuclear import factor.";
RL   J. Cell Biol. 143:309-318(1998).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-574 AND LYS-824, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [14]
RP   INTERACTION WITH CFTR.
RX   PubMed=20933420; DOI=10.1016/j.cub.2010.09.012;
RA   Bagnat M., Navis A., Herbstreith S., Brand-Arzamendi K., Curado S.,
RA   Gabriel S., Mostov K., Huisken J., Stainier D.Y.;
RT   "Cse1l is a negative regulator of CFTR-dependent fluid secretion.";
RL   Curr. Biol. 20:1840-1845(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-112 AND SER-931, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-931, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [21]
RP   VARIANT [LARGE SCALE ANALYSIS] PHE-842.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Export receptor for importin-alpha. Mediates importin-alpha
CC       re-export from the nucleus to the cytoplasm after import substrates
CC       (cargos) have been released into the nucleoplasm. In the nucleus binds
CC       cooperatively to importin-alpha and to the GTPase Ran in its active
CC       GTP-bound form. Docking of this trimeric complex to the nuclear pore
CC       complex (NPC) is mediated through binding to nucleoporins. Upon transit
CC       of a nuclear export complex into the cytoplasm, disassembling of the
CC       complex and hydrolysis of Ran-GTP to Ran-GDP (induced by RANBP1 and
CC       RANGAP1, respectively) cause release of the importin-alpha from the
CC       export receptor. CSE1L/XPO2 then return to the nuclear compartment and
CC       mediate another round of transport. The directionality of nuclear
CC       export is thought to be conferred by an asymmetric distribution of the
CC       GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus.
CC       {ECO:0000269|PubMed:9323134}.
CC   -!- SUBUNIT: Found in a complex with CSE1L/XPO2, Ran and KPNA2
CC       (PubMed:9323134, PubMed:9786944). Binds with high affinity to importin-
CC       alpha only in the presence of RanGTP. The complex is dissociated by the
CC       combined action of RanBP1 and RanGAP1 (PubMed:9323134). Interacts with
CC       CFTR (PubMed:20933420). {ECO:0000269|PubMed:20933420,
CC       ECO:0000269|PubMed:9323134, ECO:0000269|PubMed:9786944}.
CC   -!- INTERACTION:
CC       P55060; Q96JQ5: MS4A4A; NbExp=2; IntAct=EBI-286709, EBI-12820341;
CC       P55060; Q15077: P2RY6; NbExp=2; IntAct=EBI-286709, EBI-10235794;
CC       P55060; Q9Y275: TNFSF13B; NbExp=2; IntAct=EBI-286709, EBI-519169;
CC       P55060; P04637: TP53; NbExp=5; IntAct=EBI-286709, EBI-366083;
CC       P55060; Q9H1C4: UNC93B1; NbExp=2; IntAct=EBI-286709, EBI-4401271;
CC       P55060; Q9BTM9: URM1; NbExp=2; IntAct=EBI-286709, EBI-714589;
CC       P55060; O95183: VAMP5; NbExp=2; IntAct=EBI-286709, EBI-10191195;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:9323134}. Nucleus
CC       {ECO:0000269|PubMed:9323134}. Note=Shuttles between the nucleus and the
CC       cytoplasm. {ECO:0000269|PubMed:9323134}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=A;
CC         IsoId=P55060-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P55060-2; Sequence=VSP_001222, VSP_001223;
CC       Name=3;
CC         IsoId=P55060-3; Sequence=VSP_001224, VSP_001225;
CC       Name=4;
CC         IsoId=P55060-4; Sequence=VSP_047203;
CC   -!- TISSUE SPECIFICITY: Detected in brain, placenta, ovary, testis and
CC       trachea (at protein level) (PubMed:10331944). Widely expressed
CC       (PubMed:10331944). Highly expressed in testis and in proliferating
CC       cells (PubMed:7479798, PubMed:10331944). {ECO:0000269|PubMed:10331944,
CC       ECO:0000269|PubMed:7479798}.
CC   -!- SIMILARITY: Belongs to the XPO2/CSE1 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="https://atlasgeneticsoncology.org/gene/40159/CSE1L";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U33286; AAC50367.1; -; mRNA.
DR   EMBL; AF053640; AAC35007.1; -; mRNA.
DR   EMBL; AF053641; AAC35008.1; -; mRNA.
DR   EMBL; AF053642; AAC35009.1; -; mRNA.
DR   EMBL; AF053651; AAC35297.1; -; Genomic_DNA.
DR   EMBL; AF053644; AAC35297.1; JOINED; Genomic_DNA.
DR   EMBL; AF053645; AAC35297.1; JOINED; Genomic_DNA.
DR   EMBL; AF053646; AAC35297.1; JOINED; Genomic_DNA.
DR   EMBL; AF053647; AAC35297.1; JOINED; Genomic_DNA.
DR   EMBL; AF053648; AAC35297.1; JOINED; Genomic_DNA.
DR   EMBL; AF053649; AAC35297.1; JOINED; Genomic_DNA.
DR   EMBL; AF053650; AAC35297.1; JOINED; Genomic_DNA.
DR   EMBL; EF426455; ABO15009.1; -; mRNA.
DR   EMBL; AK312306; BAG35231.1; -; mRNA.
DR   EMBL; AL121903; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL133174; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471077; EAW75676.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75677.1; -; Genomic_DNA.
DR   EMBL; BC108309; AAI08310.1; -; mRNA.
DR   EMBL; BC109313; AAI09314.1; -; mRNA.
DR   EMBL; BC109314; AAI09315.1; -; mRNA.
DR   CCDS; CCDS13412.1; -. [P55060-1]
DR   CCDS; CCDS58773.1; -. [P55060-4]
DR   PIR; I39166; I39166.
DR   RefSeq; NP_001243064.1; NM_001256135.1. [P55060-4]
DR   RefSeq; NP_001307.2; NM_001316.3. [P55060-1]
DR   RefSeq; XP_011526901.1; XM_011528599.2.
DR   AlphaFoldDB; P55060; -.
DR   SMR; P55060; -.
DR   BioGRID; 107821; 299.
DR   CORUM; P55060; -.
DR   DIP; DIP-32573N; -.
DR   IntAct; P55060; 74.
DR   MINT; P55060; -.
DR   STRING; 9606.ENSP00000262982; -.
DR   TCDB; 1.I.1.1.3; the nuclear pore complex (npc) family.
DR   GlyGen; P55060; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P55060; -.
DR   MetOSite; P55060; -.
DR   PhosphoSitePlus; P55060; -.
DR   SwissPalm; P55060; -.
DR   BioMuta; CSE1L; -.
DR   DMDM; 62297557; -.
DR   EPD; P55060; -.
DR   jPOST; P55060; -.
DR   MassIVE; P55060; -.
DR   MaxQB; P55060; -.
DR   PaxDb; P55060; -.
DR   PeptideAtlas; P55060; -.
DR   ProteomicsDB; 30232; -.
DR   ProteomicsDB; 56771; -. [P55060-1]
DR   ProteomicsDB; 56772; -. [P55060-2]
DR   ProteomicsDB; 56773; -. [P55060-3]
DR   Antibodypedia; 28372; 595 antibodies from 40 providers.
DR   DNASU; 1434; -.
DR   Ensembl; ENST00000262982.3; ENSP00000262982.2; ENSG00000124207.17. [P55060-1]
DR   Ensembl; ENST00000396192.7; ENSP00000379495.3; ENSG00000124207.17. [P55060-4]
DR   GeneID; 1434; -.
DR   KEGG; hsa:1434; -.
DR   MANE-Select; ENST00000262982.3; ENSP00000262982.2; NM_001316.4; NP_001307.2.
DR   UCSC; uc002xty.5; human. [P55060-1]
DR   AGR; HGNC:2431; -.
DR   CTD; 1434; -.
DR   DisGeNET; 1434; -.
DR   GeneCards; CSE1L; -.
DR   HGNC; HGNC:2431; CSE1L.
DR   HPA; ENSG00000124207; Low tissue specificity.
DR   MIM; 601342; gene.
DR   neXtProt; NX_P55060; -.
DR   OpenTargets; ENSG00000124207; -.
DR   PharmGKB; PA26933; -.
DR   VEuPathDB; HostDB:ENSG00000124207; -.
DR   eggNOG; KOG1992; Eukaryota.
DR   GeneTree; ENSGT00550000074884; -.
DR   HOGENOM; CLU_009614_0_0_1; -.
DR   InParanoid; P55060; -.
DR   OMA; YRYEFKS; -.
DR   OrthoDB; 178772at2759; -.
DR   PhylomeDB; P55060; -.
DR   TreeFam; TF300473; -.
DR   PathwayCommons; P55060; -.
DR   SignaLink; P55060; -.
DR   BioGRID-ORCS; 1434; 836 hits in 1166 CRISPR screens.
DR   ChiTaRS; CSE1L; human.
DR   GenomeRNAi; 1434; -.
DR   Pharos; P55060; Tbio.
DR   PRO; PR:P55060; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   RNAct; P55060; protein.
DR   Bgee; ENSG00000124207; Expressed in endothelial cell and 217 other tissues.
DR   ExpressionAtlas; P55060; baseline and differential.
DR   Genevisible; P55060; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005635; C:nuclear envelope; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0005049; F:nuclear export signal receptor activity; IBA:GO_Central.
DR   GO; GO:0031267; F:small GTPase binding; IEA:InterPro.
DR   GO; GO:0006611; P:protein export from nucleus; IBA:GO_Central.
DR   GO; GO:0006606; P:protein import into nucleus; IBA:GO_Central.
DR   Gene3D; 1.25.10.10; Leucine-rich Repeat Variant; 1.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR001494; Importin-beta_N.
DR   InterPro; IPR005043; XPO2_C.
DR   InterPro; IPR013713; XPO2_central.
DR   PANTHER; PTHR10997:SF8; EXPORTIN-2; 1.
DR   PANTHER; PTHR10997; IMPORTIN-7, 8, 11; 1.
DR   Pfam; PF03378; CAS_CSE1; 1.
DR   Pfam; PF08506; Cse1; 1.
DR   Pfam; PF03810; IBN_N; 1.
DR   SMART; SM00913; IBN_N; 1.
DR   SUPFAM; SSF48371; ARM repeat; 1.
DR   PROSITE; PS50166; IMPORTIN_B_NT; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cytoplasm; Direct protein sequencing;
KW   Nucleus; Phosphoprotein; Protein transport; Reference proteome; Transport.
FT   CHAIN           1..971
FT                   /note="Exportin-2"
FT                   /id="PRO_0000117287"
FT   DOMAIN          29..102
FT                   /note="Importin N-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00115"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000269|Ref.8, ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:22223895, ECO:0007744|PubMed:22814378"
FT   MOD_RES         112
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         574
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         824
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         931
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   VAR_SEQ         190..195
FT                   /note="ATIELC -> VWNASW (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10331944"
FT                   /id="VSP_001222"
FT   VAR_SEQ         196..971
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10331944"
FT                   /id="VSP_001223"
FT   VAR_SEQ         257..312
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:11703094"
FT                   /id="VSP_047203"
FT   VAR_SEQ         943..945
FT                   /note="VPS -> TYF (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10331944"
FT                   /id="VSP_001224"
FT   VAR_SEQ         946..971
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10331944"
FT                   /id="VSP_001225"
FT   VARIANT         754
FT                   /note="I -> V (in dbSNP:rs2229042)"
FT                   /id="VAR_029327"
FT   VARIANT         842
FT                   /note="C -> F (in a colorectal cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036558"
FT   VARIANT         968
FT                   /note="V -> L (in dbSNP:rs3505)"
FT                   /id="VAR_048836"
FT   CONFLICT        231..233
FT                   /note="FED -> WEG (in Ref. 1; AAC50367 and 2; AAC35008)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        514
FT                   /note="E -> G (in Ref. 1; AAC50367 and 2; AAC35008)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        538
FT                   /note="A -> T (in Ref. 3; ABO15009)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        848
FT                   /note="K -> N (in Ref. 1; AAC50367)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        934
FT                   /note="K -> M (in Ref. 1; AAC50367)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   971 AA;  110417 MW;  08E837AB5008EBFD CRC64;
     MELSDANLQT LTEYLKKTLD PDPAIRRPAE KFLESVEGNQ NYPLLLLTLL EKSQDNVIKV
     CASVTFKNYI KRNWRIVEDE PNKICEADRV AIKANIVHLM LSSPEQIQKQ LSDAISIIGR
     EDFPQKWPDL LTEMVNRFQS GDFHVINGVL RTAHSLFKRY RHEFKSNELW TEIKLVLDAF
     ALPLTNLFKA TIELCSTHAN DASALRILFS SLILISKLFY SLNFQDLPEF FEDNMETWMN
     NFHTLLTLDN KLLQTDDEEE AGLLELLKSQ ICDNAALYAQ KYDEEFQRYL PRFVTAIWNL
     LVTTGQEVKY DLLVSNAIQF LASVCERPHY KNLFEDQNTL TSICEKVIVP NMEFRAADEE
     AFEDNSEEYI RRDLEGSDID TRRRAACDLV RGLCKFFEGP VTGIFSGYVN SMLQEYAKNP
     SVNWKHKDAA IYLVTSLASK AQTQKHGITQ ANELVNLTEF FVNHILPDLK SANVNEFPVL
     KADGIKYIMI FRNQVPKEHL LVSIPLLINH LQAESIVVHT YAAHALERLF TMRGPNNATL
     FTAAEIAPFV EILLTNLFKA LTLPGSSENE YIMKAIMRSF SLLQEAIIPY IPTLITQLTQ
     KLLAVSKNPS KPHFNHYMFE AICLSIRITC KANPAAVVNF EEALFLVFTE ILQNDVQEFI
     PYVFQVMSLL LETHKNDIPS SYMALFPHLL QPVLWERTGN IPALVRLLQA FLERGSNTIA
     SAAADKIPGL LGVFQKLIAS KANDHQGFYL LNSIIEHMPP ESVDQYRKQI FILLFQRLQN
     SKTTKFIKSF LVFINLYCIK YGALALQEIF DGIQPKMFGM VLEKIIIPEI QKVSGNVEKK
     ICAVGITKLL TECPPMMDTE YTKLWTPLLQ SLIGLFELPE DDTIPDEEHF IDIEDTPGYQ
     TAFSQLAFAG KKEHDPVGQM VNNPKIHLAQ SLHKLSTACP GRVPSMVSTS LNAEALQYLQ
     GYLQAASVTL L
//
